Literature DB >> 18373926

[Frequency of attendance and degree of control of type-2 diabetic patients].

María Trinidad Ortiz Tobarra1, Domingo Orozco Beltrán, Vicente Gil Guillén, Cecilia Terol Moltó.   

Abstract

OBJECTIVE: To analyse whether the number of doctor's appointments for type-2 diabetes patients is linked to the degree of control of his/her illness.
SETTING: Primary care. Two teaching health centres in the public network (Petrer 1 and Petrer 2, Alicante, Spain).
DESIGN: Retrospective, observational study. Review of computerised clinical histories and direct interview with patients. Patients with DM2 included in Diabetes Programme (DP); 18-month follow-up (January 2003-June 2004). SAMPLE SIZE: 86 patients (mean, 15 visits/year; SD, 7.1; alpha, 0.02; and accuracy to 2%). RANDOMISED SAMPLING: Study factor was number of visits. Evaluation criterion was difference in glycosylated haemoglobin (A(1c)) between start and end. Characteristics of the patients, characteristics of the illness and numbers of changes in treatment done were analysed. Statistical tests were: chi(2), Student t test, confidence intervals, and multivariate analysis.
RESULTS: Mean age was 65.5 (95% CI, 63.5-67.5); women, 57%; years of disease's evolution, 7.07 (95% CI, 5.6-8.5). Treatment was: diet, 12.8%; ADOs, 61.6%; ADO+insulin, 17.4%; insulin, 8.1%. Number of visits to the HC: total, 28.8 (95% CI, 26.5-31.2); medical, DP 4.7 (95% CI, 4.1-5.2); nursing DP, 11 (95% CI, 9.9-12.1). Changes of treatment were 1.73 (95% CI, 1.3-2.1); initial A1C, 7.0 (95% CI, 6.6-7.3), and final A1C, 6.9 (95% CI, 6.7-7.1). On multivariate analysis, the number of changes in the treatment (beta=-0.430; P=.007) had 0an association, but the number of visits (beta=-0.273; P=.215) and the other variables analysed had no statistical association.
CONCLUSIONS: Improvement in control of glycosylated haemoglobin was not related to the number of visits to the doctor, but was related to changes in treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18373926     DOI: 10.1157/13116629

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  5 in total

1.  Towards a more efficient diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes - The EFFIMODI trial. Design of a randomised controlled patient-preference equivalence trial in primary care.

Authors:  Paulien R Wermeling; Maureen van den Donk; Kees J Gorter; G Ardine de Wit; Yolanda van der Graaf; Guy Ehm Rutten
Journal:  BMC Fam Pract       Date:  2010-05-11       Impact factor: 2.497

Review 2.  Uncovering heart failure with preserved ejection fraction in patients with type 2 diabetes in primary care: time for a change.

Authors:  L J M Boonman-de Winter; M J Cramer; A W Hoes; F H Rutten
Journal:  Neth Heart J       Date:  2016-04       Impact factor: 2.380

3.  Breaking Therapeutic Inertia in Type 2 Diabetes: Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm.

Authors:  Anna M Lucas Martín; Elena Guanyabens; R Zavala-Arauco; Joaquín Chamorro; Maria Luisa Granada; Didac Mauricio; Manuel Puig-Domingo
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

4.  Follow-up frequency and clinical outcomes in patients with type 2 diabetes: A prospective analysis based on multicenter real-world data.

Authors:  Qiubo Zhao; Hongwei Li; Qicheng Ni; Yuancheng Dai; Qidong Zheng; Yufan Wang; Tingyu Ke; Li Li; Dong Zhao; Qijuan Dong; Bangqun Ji; Juan Shi; Ying Peng; Yifei Zhang; Fengmei Xu; Weiqing Wang
Journal:  J Diabetes       Date:  2022-05       Impact factor: 4.530

5.  Effectiveness of a new health care organization model in primary care for chronic cardiovascular disease patients based on a multifactorial intervention: the PROPRESE randomized controlled trial.

Authors:  Domingo Orozco-Beltran; Esther Ruescas-Escolano; Ana Isabel Navarro-Palazón; Alberto Cordero; María Gaubert-Tortosa; Jorge Navarro-Perez; Concepción Carratalá-Munuera; Salvador Pertusa-Martínez; Enrique Soler-Bahilo; Francisco Brotons-Muntó; Jose Bort-Cubero; Miguel Angel Nuñez-Martinez; Vicente Bertomeu-Martinez; Vicente Francisco Gil-Guillen
Journal:  BMC Health Serv Res       Date:  2013-08-02       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.